Eliem Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy ELYM

*Your capital is at risk

$5.11

+0 (+0%)

At Close: Dec 31, 2024

Currently predicting for Thu, 6 Aug 2026

ELYM Live board

Community Bull/Bear

Target Next close

Join the ELYM prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

ELYM Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For ELYM

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

ELYM Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT ELIEM THERAPEUTICS, INC.

Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase IIa clinical trial; and ETX-155 for the treatment of major depressive disorder, perimenopausal depression...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
FCX $62.63	7.46%	Jul 31
MC $67.08	2.40%	Jul 31
ARW $212.85	6.96%	Jul 30
BIIB $202.19	3.10%	Jul 24
F FERG $230.67	10.77%	Jul 24

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by